The Latest in CLL

CLL Index proves accurate in predicting survival, time to treat

February 5, 2018

CLL

VIDEO: Practice changers out of ASH 2017

January 25, 2018

CLL drug in limited supply outside U.S.

January 25, 2018

Venetoclax/rituximab boosts PFS in relapsed/refractory CLL

December 27, 2017

CLL

VIDEO: Venetoclax/rituximab prolongs PFS in relapsed/refractory CLL

December 12, 2017

CLL drug combinations induce MRD negativity

December 11, 2017

CLL

CLARITY: Ibrutinib/venetoclax combo results look promising for relapsed/refractory CLL

December 10, 2017

CLL

Late-breaking abstracts highlight treatment advances in CLL, myeloma, and more

November 22, 2017

Studies need to address best follow-on therapy to ibrutinib in CLL

November 18, 2017

CLL

Idelalisib efficacy against CLL tarnished by toxicity

October 28, 2017

CLL

Deep remission or long-term control? Choice is key in early CLL

October 27, 2017

CLL

M13-982 trial in del(17p) CLL: High, durable response rates to venetoclax

July 26, 2017

CLL

Ibrutinib and bleeding complications in Mohs surgery

July 20, 2017

CLL

First-line obinutuzumab monotherapy in CLL linked to good response, reduced toxicity

July 13, 2017

CLL

NF-kB inhibitor IT-901 shows promise in Richter syndrome

July 5, 2017

CLL